Symptoms of anxiety and depression in suspected/confirmed cases of covid-19 in pregnant and puerperal women
International Journal of Development Research
Symptoms of anxiety and depression in suspected/confirmed cases of covid-19 in pregnant and puerperal women
Received 18th January, 2021; Received in revised form 20th January, 2021; Accepted 04th February, 2021; Published online 30th March, 2021
Copyright © 2021, Vanessa da Frota Santos et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
This study aimed to estimate the occurrence of signs and symptoms of anxiety and depression in women with confirmed and/or suspected diagnosis of COVID-19 and the associated sociodemographic and clinical characteristics. This is a cross-sectional study conducted on 49 women admitted to a reference maternity hospital in Fortaleza, state of Ceará, Brazil between May and June 2020. Two instruments were applied: a sociodemographic questionnaire and the anxiety and depression scale. It was estimated that 28.57% of women had symptoms of anxiety and 38.77% had symptoms of depression. There was a statistically significant association regarding the presence of anxiety in cases in which the patient had dyspnea (p=0.037; odds ratio=2.85; CI=0.76-14.55), anosmia (p=0.039; odds ratio=3.25; CI=0.75-24.80), and myalgia (p=0.024; odds ratio=5.02; CI=0.86-130.70). It is concluded that women are exposed to symptoms of anxiety and depression, with depression symptoms being more prevalent in pregnant women. Conversely, anxiety was related to women having symptoms such as dyspnea, anosmia, and myalgia.
